Publication | Closed Access

Hemodynamic response, arrhythmic risk, and overall safety of Regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients

AsthmaBronchial Asthma PatientsRadiologyPulmonary CirculationCardiovascular DiseaseMedicineOverall SafetyPublic HealthHemodynamic ResponseCardiologyPulmonary Vascular DiseaseAnesthesiologyCardiovascular Imaging